http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020187674-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2020-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4461865f4b0fdd8e5bd76ea433ae11c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b5ff66844ffa42a0061e8713cb3a936 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb373eaf5938c563ba5820b9955dea9 |
| publicationDate | 2020-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020187674-A1 |
| titleOfInvention | Crystalline (s)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl][3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl]methanone hemisuccinate |
| abstract | The present invention relates to crystalline cobimetinib hemisuccinate and a process for its preparation. The invention also relates to a pharmaceutical composition comprising crystalline cobimetinib hemisuccinate, preferably in a predetermined and/or effective amount and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used for the treatment of cancer, in particular for the treatment of melanoma. |
| priorityDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.